
Maharishi V. Khirodhar
Examiner (ID: 10559, Phone: (571)270-7909 , Office: P/2463 )
| Most Active Art Unit | 2463 |
| Art Unit(s) | 2463, 2416 |
| Total Applications | 881 |
| Issued Applications | 739 |
| Pending Applications | 63 |
| Abandoned Applications | 97 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5069039
[patent_doc_number] => 20070190140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Pharmaceutical Composition in the Form of a Gastric-Resident Tablet Containing an Active Principle'
[patent_app_type] => utility
[patent_app_number] => 11/675712
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5157
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20070190140.pdf
[firstpage_image] =>[orig_patent_app_number] => 11675712
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/675712 | Pharmaceutical Composition in the Form of a Gastric-Resident Tablet Containing an Active Principle | Feb 15, 2007 | Abandoned |
Array
(
[id] => 10857011
[patent_doc_number] => 08883205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Microtablet-based pharmaceutical preparation'
[patent_app_type] => utility
[patent_app_number] => 12/223833
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2588
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12223833
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223833 | Microtablet-based pharmaceutical preparation | Feb 8, 2007 | Issued |
Array
(
[id] => 5236122
[patent_doc_number] => 20070128279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Extended Release Dosage Form'
[patent_app_type] => utility
[patent_app_number] => 11/673066
[patent_app_country] => US
[patent_app_date] => 2007-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16363
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11673066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/673066 | Extended release dosage form | Feb 8, 2007 | Issued |
Array
(
[id] => 8113867
[patent_doc_number] => 08158149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Threo-DOPS controlled release formulation'
[patent_app_type] => utility
[patent_app_number] => 11/698974
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4066
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158149.pdf
[firstpage_image] =>[orig_patent_app_number] => 11698974
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/698974 | Threo-DOPS controlled release formulation | Jan 28, 2007 | Issued |
Array
(
[id] => 5538621
[patent_doc_number] => 20090220426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Biodegradable Inverted-Opal Structure, Method for Manufacturing and Using the Same, and Medical Implant Comprising the Biodegradable Inverted-Opal Structure'
[patent_app_type] => utility
[patent_app_number] => 12/223344
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10121
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220426.pdf
[firstpage_image] =>[orig_patent_app_number] => 12223344
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223344 | Biodegradable Inverted-Opal Structure, Method for Manufacturing and Using the Same, and Medical Implant Comprising the Biodegradable Inverted-Opal Structure | Jan 17, 2007 | Abandoned |
Array
(
[id] => 4988090
[patent_doc_number] => 20070154429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'PERFLUOROCYCLOBUTANE CROSSLINKED HYDROGELS'
[patent_app_type] => utility
[patent_app_number] => 11/614389
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154429.pdf
[firstpage_image] =>[orig_patent_app_number] => 11614389
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/614389 | Perfluorocyclobutane crosslinked hydrogels | Dec 20, 2006 | Issued |
Array
(
[id] => 5079243
[patent_doc_number] => 20070122467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'ANAESTHETIC FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/612176
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7096
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122467.pdf
[firstpage_image] =>[orig_patent_app_number] => 11612176
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612176 | ANAESTHETIC FORMULATIONS | Dec 17, 2006 | Abandoned |
Array
(
[id] => 9827868
[patent_doc_number] => 08937096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-20
[patent_title] => 'Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder'
[patent_app_type] => utility
[patent_app_number] => 11/612222
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23660
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11612222
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/612222 | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder | Dec 17, 2006 | Issued |
Array
(
[id] => 4983526
[patent_doc_number] => 20070088085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 11/639190
[patent_app_country] => US
[patent_app_date] => 2006-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7175
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20070088085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11639190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/639190 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands | Dec 14, 2006 | Issued |
Array
(
[id] => 5252879
[patent_doc_number] => 20070134335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY'
[patent_app_type] => utility
[patent_app_number] => 11/610393
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6759
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134335.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610393
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610393 | POLYPEPTIDES WITH THE CAPACITY TO ENTRAP DRUGS AND RELEASE THEM IN A CONTROLLED WAY | Dec 12, 2006 | Abandoned |
Array
(
[id] => 9427128
[patent_doc_number] => 08703199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Pharmaceutical compositions of adsorbates of amorphous drug'
[patent_app_type] => utility
[patent_app_number] => 11/566408
[patent_app_country] => US
[patent_app_date] => 2006-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69640
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11566408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/566408 | Pharmaceutical compositions of adsorbates of amorphous drug | Dec 3, 2006 | Issued |
Array
(
[id] => 4982415
[patent_doc_number] => 20070086973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-19
[patent_title] => 'Drug delivery systems for photodynamic therapy'
[patent_app_type] => utility
[patent_app_number] => 11/601559
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25079
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20070086973.pdf
[firstpage_image] =>[orig_patent_app_number] => 11601559
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/601559 | Drug delivery systems for photodynamic therapy | Nov 16, 2006 | Issued |
Array
(
[id] => 9344544
[patent_doc_number] => 08663690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-04
[patent_title] => 'Method for nanoencapsulation'
[patent_app_type] => utility
[patent_app_number] => 12/446553
[patent_app_country] => US
[patent_app_date] => 2006-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5815
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446553
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/446553 | Method for nanoencapsulation | Oct 30, 2006 | Issued |
Array
(
[id] => 5265782
[patent_doc_number] => 20090118467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Macromolecular Compounds Having Controlled Stoichiometry'
[patent_app_type] => utility
[patent_app_number] => 12/091233
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 78669
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091233 | Macromolecular compounds having controlled stoichiometry | Oct 24, 2006 | Issued |
Array
(
[id] => 5204564
[patent_doc_number] => 20070026045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Reinforced matrices'
[patent_app_type] => utility
[patent_app_number] => 11/543432
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6234
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026045.pdf
[firstpage_image] =>[orig_patent_app_number] => 11543432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/543432 | Reinforced matrices | Oct 4, 2006 | Abandoned |
Array
(
[id] => 5112517
[patent_doc_number] => 20070196432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'ANTIMICROBIAL LENSES AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 11/537941
[patent_app_country] => US
[patent_app_date] => 2006-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9680
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196432.pdf
[firstpage_image] =>[orig_patent_app_number] => 11537941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/537941 | ANTIMICROBIAL LENSES AND METHODS OF THEIR USE | Oct 1, 2006 | Abandoned |
Array
(
[id] => 5241803
[patent_doc_number] => 20070020295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'CONTROLLED RELEASE NEUROTOXIN SYSTEM AND METHOD'
[patent_app_type] => utility
[patent_app_number] => 11/535230
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17861
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020295.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535230 | CONTROLLED RELEASE NEUROTOXIN SYSTEM AND METHOD | Sep 25, 2006 | Abandoned |
Array
(
[id] => 5171280
[patent_doc_number] => 20070071711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'FORMULATIONS FOR TOPICAL DELIVERY OF BIOACTIVE SUBSTANCES AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 11/535213
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4636
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20070071711.pdf
[firstpage_image] =>[orig_patent_app_number] => 11535213
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/535213 | Formulations for topical delivery of bioactive substances and methods for their use | Sep 25, 2006 | Issued |
Array
(
[id] => 7691338
[patent_doc_number] => 20070232695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Gelled Periodontal Anesthetic Preparation'
[patent_app_type] => utility
[patent_app_number] => 11/534552
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5724
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11534552
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/534552 | Gelled Periodontal Anesthetic Preparation | Sep 21, 2006 | Abandoned |
Array
(
[id] => 6421418
[patent_doc_number] => 20100151011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'SOLID ORALLY ADMINISTERABLE PHARMACEUTICAL DOSAGE FORMS WITH RAPID ACTIVE PRINCIPLE RELEASE'
[patent_app_type] => utility
[patent_app_number] => 12/089148
[patent_app_country] => US
[patent_app_date] => 2006-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6005
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151011.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089148
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089148 | Solid orally administerable pharmaceutical dosage forms with rapid active principle release | Sep 20, 2006 | Issued |